LBA39IMmotion150: Novel radiological endpoints and updated data from a randomized phase II trial investigating atezolizumab (atezo) with or without bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC)
暂无分享，去创建一个
A. Ravaud | M. Gore | T. Powles | R. Motzer | M. Atkins | B. Rini | M. Maio | V. Grünwald | B. Escudier | L. Fong | S. Pal | R. Joseph | S. Bracarda | D. McDermott | A. Thobhani | C. Schiff | M. Staehler | C. Rodriguez | M. Huseni | Jianhong Qiu